Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Original Article

Volume 5, Number 3, September 2016, pages 94-98


Management of Arthropathy in Moderately Deficient Factor VII Patients: Results From Hospital Developed Treatment Protocol

Tables

Table 1. Treatment Regimen for Patients Diagnosed With Moderate Deficiency of Factor VII
 
Period of rFVII administrationrFVII dose for patients with moderate factor VII deficiency (> 1 and < 10 IU/dL)
Pre-surgery15 - 25 μg/kg
On the surgery day (8 and 16 h, respectively)10 - 20 μg/kg
Rest of the days admitted in hospital15 - 20 μg/kg

 

Table 2. Details of Patients, Surgery, Dosing and Outcome
 
Patient no.Severity of diseaseSurgical procedureTreatment durationNo. of dosesTotal dose of rFVII on surgical day (μg/kg)Total dose of rFVII on subsequent days (μg/kg)Dosing range (μg/kg)Total amount of rFVII consumed (mg)
1ModerateComplete hip replacement13295428812 - 3022.23
2ModerateComplete hip replacement14314028010 - 2023.04
3ModerateComplete hip replacement13293526010 - 1522.42
4ModerateArthroscopy of shoulder1016451951516.8
5ModerateArthroscopy of ankle10166028520 - 2521.39
6ModerateArthroscopy of knee12163513010 - 159.57